ROSA MARÍA
AYALA DÍAZ
Profesora titular de universidad
Complejo Hospitalario de Toledo
Toledo, EspañaPublicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (9)
2022
-
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Scientific Reports, Vol. 12, Núm. 1
2019
2018
-
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Annals of Hematology, Vol. 97, Núm. 11, pp. 2089-2098
2017
2016
-
Leucemia mieloide crónica en España: sus características de presentación han cambiado. Sección española del registro poblacional EUTOS
Revista Clinica Espanola, Vol. 216, Núm. 6, pp. 293-300
2013
-
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
British Journal of Haematology, Vol. 161, Núm. 5, pp. 667-676
-
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera
Molecular Cancer, Vol. 12, Núm. 1
2011
-
Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
Annals of Hematology, Vol. 90, Núm. 8, pp. 939-946
-
Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation
Journal of Clinical Pathology, Vol. 64, Núm. 11, pp. 1010-1013